T2 Biosystems, Inc. 4 SEC Filings

Filed On	Filing
02 Jan 2025	Form 4: Liebman Seymour, Director Granted 25,000 Restricted Stock Units
02 Jan 2025	Form 4: Giffin Brett A., Chief Commercial Officer Granted 360,000 Restricted Stock Units
02 Jan 2025	Form 4: Adams Laura Lee, Director Granted 25,000 Restricted Stock Units
02 Jan 2025	Form 4: Cumming John W, Director Granted 35,000 Restricted Stock Units
02 Jan 2025	Form 4: Gibbs Michael Terrence, General Counsel Granted 380,000 Restricted Stock Units
02 Jan 2025	Form 4: Saunders Ninfa, Director Granted 25,000 Restricted Stock Units
02 Jan 2025	Form 4: Toft Robin, Director Granted 25,000 Restricted Stock Units
02 Jan 2025	Form 4: Sperzel John J Iii, Director Granted 980,000 Restricted Stock Units
02 Jan 2025	Form 4: Elsbree David B, Director Granted 25,000 Restricted Stock Units
02 Jan 2025	Form 4: Sprague John M, CFO Granted 360,000 Restricted Stock Units
17 Sep 2024	Form 4: Elsbree David B, Director Sold 55 shares ($133)
13 May 2024	Form 4: Cr Group L.p., 10% owner and 5 others Received 1,824,800 shares by conversion
07 May 2024	Form 4: Cr Group L.p., 10% owner and 5 others Received 4,748,335 shares as a grant or award
16 Apr 2024	Form 4: Cr Group L.p., 10% owner and 5 others Received 3,280,618 shares as a grant or award · Granted 17,160.48 Series A Convertible Preferred Stock
27 Feb 2024	Form 4: Sperzel John J Iii, Director Received 67 shares by exercise or conversion
27 Feb 2024	Form 4: Sprague John M, Chief Financial Officer Received 29 shares by exercise or conversion
27 Feb 2024	Form 4: Gibbs Michael Terrence, General Counsel Received 29 shares by exercise or conversion
20 Feb 2024	Form 4: Gibbs Michael Terrence, General Counsel Received 40 shares by exercise or conversion
20 Feb 2024	Form 4: Sprague John M, Chief Financial Officer Received 40 shares by exercise or conversion · Granted 40 Restricted Stock Units
20 Feb 2024	Form 4: Sperzel John J Iii, Director Received 160 shares by exercise or conversion

Comments